Could a common stroke drug help people with a rare brain disease?

NCT ID NCT07518810

Not yet recruiting Symptom relief Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether butylphthalide, a drug used for stroke, can improve symptoms of Multiple System Atrophy (MSA), a rare and serious brain disorder. About 150 adults with MSA will take either the drug or a placebo three times a day for six months. Researchers will track symptom changes using a standard rating scale to see if the drug helps control the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple system atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SYSTEM ATROPHY

Contacts and locations

Locations

Affiliated Beijing Chaoyang Hospital of Capital Medical University

Beijing, China
HuZhou Central Hospital

Huzhou, Zhejiang, China
Ningbo Second Hospital

Ningbo, Zhejiang, China
Taizhou Hospital of Zhejiang Province

Taizhou, Zhejiang, China
The First Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China
The Second Hospital of Jiaxing

Jiaxing, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.